Cargando…
Can routine data be used to support cancer clinical trials? A historical baseline on which to build: retrospective linkage of data from the TACT (CRUK 01/001) breast cancer trial and the National Cancer Data Repository
BACKGROUND: Randomised clinical trials (RCTs) are the gold standard for evaluating new cancer treatments. They are, however, expensive to conduct, particularly where long-term follow-up of participants is required. Tracking participants via routine datasets could provide a cost-effective alternative...
Autores principales: | Kilburn, Lucy Suzanne, Aresu, Maria, Banerji, Jane, Barrett-Lee, Peter, Ellis, Paul, Bliss, Judith Margaret |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702960/ https://www.ncbi.nlm.nih.gov/pubmed/29179731 http://dx.doi.org/10.1186/s13063-017-2308-6 |
Ejemplares similares
-
Comparison of patient reported quality of life and impact of treatment side effects experienced with a taxane-containing regimen and standard anthracycline based chemotherapy for early breast cancer: 6 year results from the UK TACT trial (CRUK/01/001)
por: Hall, E., et al.
Publicado: (2014) -
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial
por: Cameron, David, et al.
Publicado: (2017) -
The challenges of long-term follow-up data collection in non-commercial, academically-led breast cancer clinical trials: the UK perspective
por: Kilburn, Lucy S, et al.
Publicado: (2014) -
Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001)
por: Nicholson, S, et al.
Publicado: (2013) -
Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phase II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK – A16037)
por: Banerjee, Susana, et al.
Publicado: (2020)